Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bolt Biotherapeutics, Inc.

0.3500
+0.01805.42%
Post-market: 0.36000.0100+2.86%19:13 EDT
Volume:35.52K
Turnover:12.18K
Market Cap:13.42M
PE:-0.21
High:0.3600
Open:0.3491
Low:0.3320
Close:0.3320
Loading ...
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 30, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 10, 2022

Major Issues Report

8-K - Current report
May 16, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 30, 2022

Major Issues Report

8-K - Current report
Mar 30, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Major Issues Report

8-K - Current report
Dec 16, 2021

Major Issues Report

8-K - Current report
Dec 09, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 19, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities